BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 6813634)

  • 41. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
    Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
    Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stabilization of hearing loss in Paget's disease with calcitonin and etidronate.
    Lando M; Hoover LA; Finerman G
    Arch Otolaryngol Head Neck Surg; 1988 Aug; 114(8):891-4. PubMed ID: 3134037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical aspects and therapy of Paget's disease (osteitis deformans)].
    Ringe JD
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1207-12. PubMed ID: 6223799
    [No Abstract]   [Full Text] [Related]  

  • 44. Paget's disease of bone: assessment and management.
    Ibbertson HK; Fraser TR; Scott DJ; Cullen JC; Henley JW; Stephens ES; Tait B; Wattie DJ
    Drugs; 1979 Jul; 18(1):33-47. PubMed ID: 157870
    [No Abstract]   [Full Text] [Related]  

  • 45. Newer agents in treating Paget's disease of bone.
    Goldfield EB
    Geriatrics; 1974 Dec; 29(12):61-9. PubMed ID: 4279196
    [No Abstract]   [Full Text] [Related]  

  • 46. [Calcitonin and calcium in the treatment of Paget's disease of bone (author's transl)].
    Rico Lenza H; Huertas García-Alejo R; Gómez Castresana F; Espinós Pérez D
    Med Clin (Barc); 1982 Mar 1-15; 78(5):179-82. PubMed ID: 7078307
    [No Abstract]   [Full Text] [Related]  

  • 47. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapeutic success in Paget disease.
    Vaisrub S
    JAMA; 1973 Jun; 224(10):1413. PubMed ID: 4634178
    [No Abstract]   [Full Text] [Related]  

  • 49. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Paget's disease.
    Wallach S
    Adv Intern Med; 1982; 27():1-43. PubMed ID: 6462035
    [No Abstract]   [Full Text] [Related]  

  • 52. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Diphosphonate and calcitonin in Paget's disease.
    Hosking DJ; Bijvoet OL
    Lancet; 1976 May; 1(7966):970. PubMed ID: 57380
    [No Abstract]   [Full Text] [Related]  

  • 55. Diagnosis and treatment of Paget's disease of bone.
    Siris ES
    Compr Ther; 1983 Sep; 9(9):47-53. PubMed ID: 6226474
    [No Abstract]   [Full Text] [Related]  

  • 56. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Procollagen-III peptide serum levels in Paget's disease of the bone.
    Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
    Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
    Alexandre C; Trillet M; Meunier P; Fischer C
    Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy.
    Walton KR; Green JR; Reeve J; Wootton R
    Bone; 1985; 6(1):29-31. PubMed ID: 3922391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Paget's disease of bone.
    Melick RA
    Med J Aust; 1985 Oct; 143(9):394-7. PubMed ID: 2932626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.